31/03/2026
About 75% of pregnant patients at risk for preeclampsia are not taking low-dose aspirin, the recommended preventive treatment, according to research presented at the American College of Cardiology (ACC) Scientific Session 2026 in New Orleans.
Despite meeting high- or moderate-risk criteria for preeclampsia, only 24% of eligible women had a documented directive or prescription for the medication, despite its relative affordability and few potential side effects. https://mdsc.pe/4m3gar5